Bausch + Lomb Overview

  • Founded
  • 1853

Founded
  • Status
  • Public

  • Employees
  • 12,800

Employees
  • Stock Symbol
  • BLCO

Stock Symbol
  • Investments
  • 27

  • Share Price
  • $17.45

  • (As of Friday Closing)

Bausch + Lomb General Information

Description

Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries.

Contact Information

Website
www.bausch.com
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Pharmaceuticals
Stock Exchange
TSE
Primary Office
  • 400 Somerset Corporate Boulevard
  • Bridgewater, NJ 08807
  • United States
+1 (800) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bausch + Lomb Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$17.45 $17.60 $12.44 - $20.07 $6.11B 350M 4.32K $0.17

Bausch + Lomb Financials Summary

In Thousands,
USD
TTM 30-Sep-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 7,523,557
Revenue 3,773,000 3,765,000 3,412,000 3,778,000
EBITDA 643,000 733,000 729,000 867,000
Net Income 58,000 182,000 (18,000) 298,000
Total Assets 10,696,000 10,823,000 11,266,000 11,468,000
Total Debt 2,438,000 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bausch + Lomb Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bausch + Lomb‘s full profile, request access.

Request a free trial

Bausch + Lomb Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United
Therapeutic Devices
Bridgewater, NJ
12,800 As of 2022
00000
0.00 0000-00-00
00000000 00000

000000

o eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim v
00000000000 0000000
Aliso Viejo, CA
000 As of 0000
00000
0000 0000-00-00
00000000 00000

000000

mmodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse
00000000000 0000000
Charenton-le-Pont, France
000000 As of 0000
000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bausch + Lomb Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RxSight Formerly VC-backed Aliso Viejo, CA 000 00000 00000000 00000
0000000 Corporation Charenton-le-Pont, France 000000 000000000
0000000000 Formerly VC-backed Carlsbad, CA 00 000.00 000000&0 000.00
000000 Formerly VC-backed Mountain View, CA 000 000.00 000000000 - 000.00
00000000 Formerly VC-backed Irvine, CA 00 0000 000000&0 0000
To view Bausch + Lomb’s complete competitors history, request access »

Bausch + Lomb Patents

Bausch + Lomb Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200375681-A1 Detachable finger-activated surgical control device Inactive 03-Jun-2019 000000000
CA-3132335-A1 Glycophospholipid polymeric network and use thereof Pending 29-Apr-2019 00000000000
EP-3962961-A1 Glycophospholipid polymeric network and use thereof Pending 29-Apr-2019 00000000000
JP-2022530253-A Glycophospholipid polymer network and its use Pending 29-Apr-2019 00000000000
US-20200339710-A1 Glycophospholipid polymeric network and use thereof Pending 29-Apr-2019 C08B37/0063 0
To view Bausch + Lomb’s complete patent history, request access »

Bausch + Lomb Executive Team (34)

Name Title Board Seat Contact Info
Joseph Papa Chief Executive Officer & Board Member
Joseph Gordon President, Global Consumer, Surgical and Vision Care
Kelly Webber Chief Human Resources Officer & Executive Vice President
Louis Yu Ph.D Chief Quality Officer & Executive Vice President
David Fisher Executive Director, Marketing, US & Global Marketing Head (Anti-Infective/Allergy)
You’re viewing 5 of 34 executive team members. Get the full list »

Bausch + Lomb Board Members (16)

Name Representing Role Since
000000 000 0000000 Self Board Member 000 0000
00000 00000 Bausch + Lomb Board Member 000 0000
00000 00000 Self Board Member 000 0000
0000 00 Self Board Member 000 0000
0000 0000000 Self Board Member 000 0000
You’re viewing 5 of 16 board members. Get the full list »

Bausch + Lomb Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bausch + Lomb Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bausch + Lomb‘s full profile, request access.

Request a free trial

Bausch + Lomb Investments & Acquisitions (27)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 17-Jan-2023 0000000000 Therapeutic Devices 000000 00
000000000 27-Jul-2022 00000 0000 0000 Surgical Devices 000000 00
00000 0000000 12-Jan-2016 0000000000 Therapeutic Devices 0000 0000
000000'0 0000 23-Oct-2015 0000000000 Diagnostic Equipment 00000 000
Innovative Sclerals 24-Apr-2015 Merger/Acquisition Therapeutic Devices 000 00000
You’re viewing 5 of 27 investments and acquisitions. Get the full list »

Bausch + Lomb Subsidiaries (1)

Company Name Industry Location Founded
00000000000 00ö000 Accessories Buenos Aires, Argentina 0000
To view Bausch + Lomb’s complete subsidiaries history, request access »

Bausch + Lomb Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 0000 00000 01-Jan-2000 000000000000000000 Completed
  • 000000 + 0000
0000000-000 01-Jan-1993 000000000000000000 Completed
  • 000000 + 0000
Minnesota Eye Consultants Corporate Completed
To view Bausch + Lomb’s complete exits history, request access »